Preparation and preclinical evaluation of 66Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical

The peptide conjugated DOTA-E-[c(RGDfK)]2 labeled with 66Ga may be attractive as a theranostic agent for tumors over-expressing αvβ3 integrins.